Kala Pharmaceuticals Inc share price logo

Kala Pharmaceuticals Inc

NASDAQ: KALA

Small Cap

$0.11

(+3.71%)

as on

Kala Pharmaceuticals Inc Stock Performance

as on May 2, 2026 at 6:59 am IST

  • Day's High

    $0.11
    $0.12

    9.09%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.10
    $20.60
    downward going graph

    7.09%

    Downside

    18627.27%

    Upside

    downward going graph

Kala Pharmaceuticals Inc share price movements today

Previous Close
$0.11
Open
$0.11
Volume
4.7M
Day's Low - High
$0.11 - $0.12
52 Week Low - High
$0.10 - $20.60

Kala Pharmaceuticals Inc Historical Returns

1 Month Return
-35.96 %
3 Month Return
-79.34 %
1 Year Return
-97.09 %
3 Year Return
-99.28 %
5 Year Return
-99.97 %

Kala Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Kala Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$97.7M

EPS (TTM)

-4.45

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-42.1M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-279.18%

Kala Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kala Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$97.7M-99.97%NA0.00%
BUY$41.3B110.54%77.5712.55%
BUY$108.7B94.28%27.9332.94%
NA$32.7BNA118.495.37%
BUY$74.1B45.73%17.2729.65%

Stock Returns calculator for Kala Pharmaceuticals Inc Stock including INR - Dollar returns

The Kala Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Kala Pharmaceuticals Inc investment value today

Current value as on today

₹3,303

Returns

-₹96,697

(-96.7%)

Returns from Kala Pharmaceuticals Inc Stock

-₹97,067 (-97.07%)

Dollar Impact

₹369 (+0.37%)

Analyst Recommendation on Kala Pharmaceuticals Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Kala Pharmaceuticals Inc. Average target price of $1.5

Kala Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Kala Pharmaceuticals Inc.

What analysts predicted

92.67%UPSIDE

Target Price

$1.5

Current Price

$0.11

Analyzed by

9 Analysts

Target

$1.50

Kala Pharmaceuticals Inc target price $1.5, a slight upside of 92.67% compared to current price of $0.11. According to 9 analysts rating.

Kala Pharmaceuticals Inc Stock’s Investor Sentiment and Interest

Investment in Kala Pharmaceuticals Inc Shares on INDmoney has dropped by -34.17% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-34.17% versus previous 30 day period

Search interest for Kala Pharmaceuticals Inc Stock has decreased by -23% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-23% versus previous 30 day period

Kala Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
0
-
-
-
0
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
-
Operating Income
-9
-11
-9
-9
-9
-10
-10
-10
-10
EBITDA
-9
-11
-9
-9
-9
-10
-10
-10
-
Interest Expense
1
1
1
1
1
1
1
0
0
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-8
-11
-9
-8
-8
-8
-11
-7
0
Income Tax Expense
-5
0
-
-
0
-
-
-
-
Net Income
-8
-11
-9
-8
-8
-8
-11
-7
0
Net Profit Margin
-12324.29%
0.00%
0.00%
0.00%
-3218.50%
0.00%
0.00%
0.00%
0.00%

Kala Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
6
6
11
3
-
-
-
Gross Profit
0
0
0
3
3
7
1
0
0
0
Operating Income
-32
-39
-64
-88
-96
-109
-81
-39
-40
-42
EBITDA
-32
-39
-63
-85
-93
-107
-80
-38
-40
-42
Interest Expense
0
1
3
8
8
8
7
5
5
3
Depreciation
-
0
0
0
0
0
0
0
0
0
Income Before Tax
-33
-42
-66
-94
-104
-142
-44
-42
-38
-26
Income Tax Expense
0
0
1
7
7
9
-44
-
-
-
Net Income
-33
-42
-66
-94
-104
-142
-44
-42
-38
-26
Net Profit Margin
0.00%
0.00%
0.00%
-1553.29%
-1639.85%
-1268.73%
-1151.64%
0.00%
0.00%
0.00%

Kala Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-11
-9
-8
-8
-8
-11
-7
0
0
Operating Cash Flow
-10
-9
-4
-4
-8
-7
-10
-4
-4
Investing Cash Flow
0
0
0
0
-
0
0
-
0
Financing Cash Flow
8
14
0
6
0
-2
0
-8
-8
Change in Cash
-2
5
-4
1
-8
-10
-10
-13
-13

Kala Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-42
-66
-94
-104
-142
-44
-42
-38
-26
Operating Cash Flow
-34
-54
-92
-90
-108
-78
-27
-29
-31
Investing Cash Flow
0
-1
-1
-78
70
62
0
0
0
Financing Cash Flow
103
124
8
160
42
-7
8
29
-11
Change in Cash
69
68
-85
-8
5
-24
-19
0
-43

Global Institutional Holdings in Kala Pharmaceuticals Inc

Funds
Holdings
ADAR1 Capital Management LLC
0.51%
State Street Corp
0.1%
XTX Topco Ltd
0.1%
Tower Research Capital LLC
0%
XTX Topco Ltd
0.18%

Kala Pharmaceuticals Inc News & Key Events

  • img

    Today's Timeline - 29 September

    Mon, 09:30 PM

    -

    Kala Bio halts KPI-012 development after trial fails to meet primary endpoints, plans workforce reduction and strategic evaluations.

Insights on Kala Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, -11.15M → 686.0K (in $), with an average increase of 416.7% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 70.0K → 254.0K (in $), with an average increase of 72.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 15.8% return, outperforming this stock by 112.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, KALA BIO Inc has experienced a drawdown of -99.3%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 92.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, KALA stock has moved down by -8.7%

About Kala Pharmaceuticals Inc

KALA BIO, Inc. a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare and severe eye diseases. The company's lead product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects; and limbal stem cell deficiency and other rare corneal diseases. Its preclinical development product consists of KPI-014 for the treatment of rare inherited retinal diseases. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.
OrganisationKala Pharmaceuticals Inc
Headquarters1167 Massachusetts Avenue, Arlington, MA, United States, 02476
IndustryBiotechnology
CEOMr. Avi Minkowitz
E-voting on sharesClick here to vote

Key Management of Kala Pharmaceuticals Inc

Name

Title

Mr. Josiah Craver CPA

Senior VP & Corporate Controller

Mr. Carl Rennie

Executive Director of Account Management

Mr. Patrick Bedell

Executive Director of Trade & Alternate Channels

Dr. Justin Hanes Ph.D.

Founder & Chair of the Scientific Advisory Board

Dr. Francis S. Mah M.D.

Chief Medical Advisor

Ms. Jill S. Steier

Executive Director of Investor Relations & Corporate Communications

Mr. Vincent Kosewski

Senior VP of Manufacturing & Supply Chain Management

Ms. Mary Reumuth CPA

Treasurer & Secretary

Mr. Avi Minkowitz

CEO, CFO & Director

FAQs

What is Kala Pharmaceuticals Inc share price today?

Kala Pharmaceuticals Inc share price today is $0.11 as on at the close of the market. Kala Pharmaceuticals Inc share today touched a day high of $0.12 and a low of $0.11.

What is the 52 week high and 52 week low for Kala Pharmaceuticals Inc share?

Kala Pharmaceuticals Inc share touched a 52 week high of $20.6 on and a 52 week low of $0.1 on . Kala Pharmaceuticals Inc stock price today i.e. is closed at $0.11,which is 99.47% down from its 52 week high and 7.63% up from its 52 week low.

What is Kala Pharmaceuticals Inc's market capitalisation today?

Kala Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Kala Pharmaceuticals Inc Stock (KALA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Kala Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kala Pharmaceuticals Inc Shares that will get you 13.6364 shares as per Kala Pharmaceuticals Inc share price of $0.11 per share as on May 2, 2026 at 1:29 am IST.

What is the minimum amount required to buy Kala Pharmaceuticals Inc Stock (KALA) from India?

Indian investors can start investing in Kala Pharmaceuticals Inc (KALA) shares with as little as ₹94.91 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.10 in Kala Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Kala Pharmaceuticals Inc share’s latest price of $0.11 as on May 2, 2026 at 1:29 am IST, you will get 90.9091 shares of Kala Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Kala Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Kala Pharmaceuticals Inc stock has given -99.97% share price returns and 28.57% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?